INmune Bio Stock Forecast - Day Median Price

INMB
 Stock
  

USD 7.15  0.43  6.40%   

INmune Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast INmune Bio historical stock prices and determine the direction of INmune Bio's future trends based on various well-known forecasting models. However, solely looking at the historical price movement is usually misleading. Macroaxis recommends to always use this module together with analysis of INmune Bio historical fundamentals such as revenue growth or operating cash flow patterns. Although INmune Bio naive historical forecasting may sometimes provide an important future outlook for the firm we recommend to always cross-verify it against solid analysis of INmune Bio systematic risk associated with finding meaningful patterns of INmune Bio fundamentals over time.
Please see Historical Fundamental Analysis of INmune Bio to cross-verify your projections.
  
The current year Receivables Turnover is expected to grow to 0.06. The current year Accounts Payable Turnover is expected to grow to 0.07. The current year Weighted Average Shares is expected to grow to about 17.4 M. The current year Weighted Average Shares Diluted is expected to grow to about 17.4 M.

Open Interest Agains t 2022-12-16 INmune Option Contracts

Although open interest is a measure utilized in the options markets, it could be used to forecast INmune Bio's spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest INmune Bio's options reflect these daily shifts, investors could use the patterns of these changes to develop long and short trading strategies INmune Bio stock based on available contracts left at the end of a trading day.
Please note, to derive more accurate forecasting about market movement from the current INmune Bio's open interest, investors have to compare it to INmune Bio's spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of INmune Bio is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in INmune. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
INmune Bio has current Day Median Price of 0.
Most investors in INmune Bio cannot accurately predict what will happen the next trading day because, historically, stock markets tend to be unpredictable and even illogical. Modeling turbulent structures requires applying different statistical methods, techniques, and algorithms to find hidden data structures or patterns within the INmune Bio's time series price data and predict how it will affect future prices. One of these methodologies is forecasting, which interprets INmune Bio's price structures and extracts relationships that further increase the generated results' accuracy.
Median Price is the statistical median of an asset price for a given trading period.
  Previous Day Median PriceDay Median PriceTrend
6.990
Check INmune Bio VolatilityBacktest INmune BioInformation Ratio  

INmune Bio Trading Date Momentum

On December 01 2022 INmune Bio was traded for  7.15  at the closing time. The top price for the day was 0.00  and the lowest listed price was  0.00 . There was no trading activity during the period 0.0. Lack of trading volume on December 1, 2022 did not cause price change. The trading delta at closing time against the current closing price is 100.00% .
The median price is the midpoint of the trading periods range.
Compare INmune Bio to competition

Other Forecasting Options for INmune Bio

For every potential investor in INmune, whether a beginner or expert, INmune Bio's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. INmune Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in INmune. Basic forecasting techniques help filter out the noise by identifying INmune Bio's price trends.

INmune Bio Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with INmune Bio stock to make a market-neutral strategy. Peer analysis of INmune Bio could also be used in its relative valuation, which is a method of valuing INmune Bio by comparing valuation metrics with similar companies.
HP IncAMN Healthcare ServicesTwist Bioscience CorpFreedom Holding CorpGlobal X NASDAQFRANKLIN MUTUAL EUROPEANBHP Group LimitedNatural Health TrendIShares MSCI USAAramark HoldingsVanguard Long-TermSeagate Technology PLCVistra Energy CorpExxon Mobil CorpSignature Bank
 Risk & Return  Correlation

INmune Bio Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of INmune Bio's price movements, , a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of INmune Bio's current price.

INmune Bio Risk Indicators

The analysis of INmune Bio's basic risk indicators is one of the essential steps in helping accuretelly forecast its future price. The process involves identifying the amount of risk involved in INmune Bio's investment and either accepting that risk or mitigating it. Along with some funamental techniques of forecasting INmune Bio stock price, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential stock investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

INmune Bio Investors Sentiment

The influence of INmune Bio's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in INmune. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.
Investor biases related to INmune Bio's public news can be used to forecast risks associated with investment in INmune. The trend in average sentiment can be used to explain how an investor holding INmune can time the market purely based on public headlines and social activities around INmune Bio. Please note that most equiteis that are difficult to arbitrage are affected by market sentiment the most.
INmune Bio's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for INmune Bio's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average INmune Bio's news discussions. The higher the estimated score, the more favorable is the investor's outlook on INmune Bio.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards INmune Bio in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, INmune Bio's short interest history, or implied volatility extrapolated from INmune Bio options trading.

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as INmune Bio using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please see Historical Fundamental Analysis of INmune Bio to cross-verify your projections. You can also try Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.

Complementary Tools for analysis

When running INmune Bio price analysis, check to measure INmune Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy INmune Bio is operating at the current time. Most of INmune Bio's value examination focuses on studying past and present price action to predict the probability of INmune Bio's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move INmune Bio's price. Additionally, you may evaluate how the addition of INmune Bio to your portfolios can decrease your overall portfolio volatility.
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Go
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Go
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Go
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Go
Is INmune Bio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of INmune Bio. If investors know INmune will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about INmune Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
120.6 M
Quarterly Revenue Growth YOY
6.0
Return On Assets
(0.19) 
Return On Equity
(0.41) 
The market value of INmune Bio is measured differently than its book value, which is the value of INmune that is recorded on the company's balance sheet. Investors also form their own opinion of INmune Bio's value that differs from its market value or its book value, called intrinsic value, which is INmune Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because INmune Bio's market value can be influenced by many factors that don't directly affect INmune Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between INmune Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine INmune Bio value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, INmune Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.